BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36232885)

  • 21. Comprehensive Pan-Cancer Mutation Density Patterns in Enhancer RNA.
    Zhang T; Yu H; Jiang L; Bai Y; Liu X; Guo Y
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancer RNAs in transcriptional regulation: recent insights.
    Chen Q; Zeng Y; Kang J; Hu M; Li N; Sun K; Zhao Y
    Front Cell Dev Biol; 2023; 11():1205540. PubMed ID: 37266452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting active enhancers with DNA methylation and histone modification.
    Luo X; Li Q; Tang Y; Liu Y; Zou Q; Zheng J; Zhang Y; Xu L
    BMC Bioinformatics; 2023 Nov; 24(1):414. PubMed ID: 37919681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genome-wide CRISPR activation screen identifies
    Uthaya Kumar DB; Yurieva M; Grassmann J; Kozhaya L; McBride CD; Unutmaz D; Williams A
    Front Mol Biosci; 2023; 10():1110445. PubMed ID: 36923642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alu transposable elements rewire enhancer-promoter network through RNA pairing.
    Wen X; Zhong S
    Mol Cell; 2023 Sep; 83(18):3234-3235. PubMed ID: 37738962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mutator-derived prognostic eRNA signature provides insight into the pathogenesis of breast cancer.
    Wang R; Gou Y; Tang M; Wang K; He H; Yang J; Yang Y; Jing Y; Tang Q
    Exp Cell Res; 2023 Oct; 431(1):113754. PubMed ID: 37611728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer.
    Lewis MW; Wisniewska K; King CM; Li S; Coffey A; Kelly MR; Regner MJ; Franco HL
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revealing eRNA interactions: TF dependency and convergent cooperativity.
    Lee SA; Kristjánsdóttir K; Kwak H
    Res Sq; 2023 Feb; ():. PubMed ID: 36909657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RGS1 Enhancer RNA Promotes Gene Transcription by Recruiting Transcription Factor FOXJ3 and Facilitates Osteoclastogenesis Through PLC-IP3R-dependent Ca
    Yuan L; Jiang N; Li Y; Wang X; Wang W
    Inflammation; 2024 Jun; ():. PubMed ID: 38904871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancer RNAs: Insights Into Their Biological Role.
    de Lara JC; Arzate-Mejía RG; Recillas-Targa F
    Epigenet Insights; 2019; 12():2516865719846093. PubMed ID: 31106290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancer RNA profiling predicts transcription factor activity.
    Azofeifa JG; Allen MA; Hendrix JR; Read T; Rubin JD; Dowell RD
    Genome Res; 2018 Feb; 28(3):334-44. PubMed ID: 29449408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing nascent transcription patterns of PROMPTs, eRNAs, and readthrough transcripts in the ENCODE4 deeply profiled cell lines.
    McShane A; Narayanan IV; Paulsen MT; Ashaka M; Blinkiewicz H; Yang NT; Magnuson B; Bedi K; Wilson TE; Ljungman M
    bioRxiv; 2024 May; ():. PubMed ID: 38645116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive identification and potential application of genetic alteration-driven enhancer RNAs for eRNA-targeted therapy in breast cancer.
    Zhao H; Zhang C; Bo L; Wang L; Liu W; Shu Y; Liu K; Liu Y; Fei M; Wang L
    Genes Dis; 2024 Sep; 11(5):101124. PubMed ID: 38868577
    [No Abstract]   [Full Text] [Related]  

  • 34. PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets.
    Zhang S; Wang J; Liu Q; McDonald WH; Bomber ML; Layden HM; Ellis J; Borinstein SC; Hiebert SW; Stengel KR
    Mol Cell; 2022 Dec; 82(23):4428-4442.e7. PubMed ID: 36395771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
    Liu D; Wang W; Wu Y; Qiu Y; Zhang L
    Curr Cancer Drug Targets; 2024; 24(5):519-533. PubMed ID: 38804344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Validation of eRNA as a Prognostic Indicator for Cervical Cancer.
    Huang L; Zhang J; Songyang Z; Xiong Y
    Biology (Basel); 2024 Mar; 13(4):. PubMed ID: 38666838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constructing eRNA-mediated gene regulatory networks to explore the genetic basis of muscle and fat-relevant traits in pigs.
    Wang C; Chen C; Lei B; Qin S; Zhang Y; Li K; Zhang S; Liu Y
    Genet Sel Evol; 2024 Apr; 56(1):28. PubMed ID: 38594607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancer RNA (eRNA) in Human Diseases.
    Wang Y; Zhang C; Wang Y; Liu X; Zhang Z
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease.
    Ren C; Liu F; Ouyang Z; An G; Zhao C; Shuai J; Cai S; Bo X; Shu W
    Sci Rep; 2017 Nov; 7(1):15518. PubMed ID: 29138457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into Enhancer RNAs: Biogenesis and Emerging Role in Brain Diseases.
    Shen Y; Huang Z; Yang R; Chen Y; Wang Q; Gao L
    Neuroscientist; 2023 Apr; 29(2):166-176. PubMed ID: 34612730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.